Symbol
| PML
| contributors: shn - updated : 21-05-2016
|
HGNC name
| promyelocytic leukemia
|
HGNC id
| 9113
|
corresponding disease(s)
|
PML
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
| germinal mutation
|  
|  
|  
|
mutated in acute promyelocytic leukemia with associates with poor prognosis and RA unresponsiveness | tumoral
| fusion
|  
|  
|  
|
fused with RARA int (15;17) in acute promyelocytic leukemia | |
Susceptibility
|
to Paget disease (PDB) |
Variant & Polymorphism
other
| rs5742915 strongly associated with PDB |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | | | |
PML-RARA degradation or therapy-triggered degradation of oncoproteins could be a general strategy to eradicate cancer stem cells |
| | | |
| PMLRAR alpha transgenic mice exhibited neutrophil differentiation impairment and acute promyelocytic leukemia | |
Pml–/– mice had smaller brains and hippocampus than Pml+/+ and Pml+/– mice although the overall organization of the brain did not appear to be affected |
|
PML-RARA-targeted DNA vaccine induces protective immunity in a mouse model of leukemia |